MELANOTAN II — CLINICAL RESEARCH-GRADE MELANOCORTIN PEPTIDE FOR RECEPTOR AND NEUROENDOCRINE PATHWAY INVESTIGATION
Scientific Overview
Melanotan II is a synthetic, cyclic peptide analog structurally derived from α-melanocyte-stimulating hormone (α-MSH). It was developed to enhance molecular stability and receptor affinity for experimental evaluation within the melanocortin receptor system.
Due to its cyclic conformation and incorporation of non-natural amino acid residues, Melanotan II exhibits increased resistance to enzymatic degradation relative to endogenous α-MSH. This structural profile makes it a useful model peptide for controlled laboratory studies examining melanocortin receptor activation and downstream signaling behavior.
Melanotan II is utilized exclusively in research and investigational settings and is intended for in vitro, in vivo, and analytical research applications only.
Primary Research Areas
• Melanocortin Receptor Pathway Analysis
Investigation of MC1R, MC3R, MC4R, and MC5R activation, receptor binding affinity, and cAMP-dependent intracellular signaling mechanisms.
• Neuroendocrine Signaling Research
Study of hypothalamic melanocortin circuitry and receptor-mediated signal transduction within central nervous system research models.
• Cyclic Peptide Engineering
Evaluation of peptide cyclization, amino acid substitution, and structural modification for stability, receptor engagement, and pharmacokinetic modeling.
• Intranasal Peptide Delivery Models
Experimental assessment of intranasal administration as a non-invasive delivery route for central melanocortin pathway exposure in controlled research environments.
• Signal Transduction and Transcriptional Regulation Studies
Analysis of melanocortin-mediated cAMP signaling cascades and downstream gene expression in cellular systems.
Mechanistic Overview
Melanotan II acts as a non-selective agonist across multiple melanocortin receptor subtypes. Upon receptor binding, it stimulates adenylate cyclase activity, resulting in increased intracellular cAMP levels and activation of associated signaling pathways.
The peptide’s cyclic structure enhances molecular persistence and receptor interaction duration, allowing researchers to examine sustained melanocortin receptor engagement and receptor signaling dynamics under controlled experimental conditions.
Melanotan II is frequently employed as a reference compound in melanocortin receptor research and structure–activity relationship studies.
Research Applications
• Melanocortin Receptor Binding and Agonist Characterization
• Cyclic Peptide Stability and Structure–Activity Studies
• Neuroendocrine Signaling Pathway Investigation
• Intranasal Peptide Delivery Research Models
• cAMP-Mediated Signal Transduction Analysis
